Historique
Bulletin de Périodique
Drug and Alcohol Dependence , Vol.120, n°1-3 - January 2012
Paru le :
02/02/2012
Article en page(s) :
1-254
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
• Smoking-related prospective memory deficits in a real-world task. Heffernan T.M., O'Neill T.S., Moss M., p. 1-6.
• Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women. Janes A.C., Smoller J.W., David S.P., Frederick B.D., Haddad S., Basu A., et al., p. 7-13.
• Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment+naltrexone compared to usual care. Otiashvili D., Kirtadze I., O'Grady K.E., Jones H.E., p. 14-21.
• Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Cerda M., Wall M., Keyes K.M., Galea S., Hasin D., p. 22-27.
• Socializing in an open drug scene: the relationship between access to private space and drug-related street disorder. Debeck K., Wood E., Qi J., Fu E., McArthur D., Montaner J., et al., p. 28-34.
• Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Callaghan R.C., Cunningham J.K., Sykes J., Kish S.J., p. 35-40.
• MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity. Salomon R.M., Karageorgiou J., Dietrich M.S., McLellan J.Y., Charboneau E.J., Blackford J.U., et al., p. 41-47.
• Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial. DeFulio A., Everly J.J., Leoutsakos J.M., Umbricht A., Fingerhood M., Bigelow G.E., et al., p. 48-54.
• Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders. Svikis D.S., Keyser-Marcus L., Stitzer M., Rieckmann T., Safford L., Loeb P., et al., p. 55-64.
• Trazodone for sleep disturbance during methadone maintenance: a double-blind, placebo-controlled trial. Stein M.D., Kurth M.E., Sharkey K.M., Anderson B.J., Corso R.P., Millman R.P., p. 65-73.
• Craving and illicit heroin use among patients in heroin-assisted treatment. Blanken P., Hendriks V.M., Koeter M.W., van Ree J.M., van den Brink W., p. 74-80.
• Factors affecting cognitive function of opiate-dependent patients. Loeber S., Nakovics H., Kniest A., Kiefer F., Mann K., Croissant B., p. 81-87.
• Linking measures of adult nicotine dependence to a common latent continuum and a comparison with adolescent patterns. Strong D.R., Schonbrun Y.C., Schaffran C., Griesler P.C., Kandel D., p. 88-98.
• Exploring age of onset as a causal link between major depression and nonmedical use of prescription medications. Schepis T.S., McCabe S.E., p. 99-104.
• Changes in the plasma proteome follows chronic opiate administration in simian immunodeficiency virus infected rhesus macaques. Wiederin J.L., Yu F., Donahoe R.M., Fox H.S., Ciborowski P., Gendelman H.E., p. 105-112.
• Alcohol consumption among HIV-positive pregnant women in KwaZulu-Natal, South Africa: prevalence and correlates. Desmond K., Milburn N., Richter L., Tomlinson M., Greco E., van Heerden A., et al., p. 113-118.
• Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia. Couture M.C., Evans J.L., Sothy N.S., Stein E.S., Sichan K., Maher L., et al., p. 119-126.
• Beyond income: material resources among drug users in economically-disadvantaged New York City neighborhoods. Ompad D.C., Nandi V., Cerda M., Crawford N., Galea S., Vlahov D., p. 127-134.
• Modafinil for the treatment of methamphetamine dependence. Anderson A.L., Li S.H., Biswas K., McSherry F., Holmes T., Iturriaga E., et al., p. 135-141.
• Male injection drug users try new drugs following U.S. deportation to Tijuana, Mexico. Robertson A.M., Rangel M.G., Lozada R., Vera A., Ojeda V.D., p. 142-148.
• Counselor training in several evidence-based psychosocial addiction treatments in private US substance abuse treatment centers. Olmstead T.A., Abraham A.J., Martino S., Roman P.M., p. 149-154.
• Stressful life events and suicidal behavior in adults with alcohol use disorders: role of event severity, timing, and type. Conner K.R., Houston R.J., Swogger M.T., Conwell Y., You S., He H., et al., p. 155-161.
• Substance use after participation in laboratory studies involving smoked cocaine self-administration. Kalapatapu R.K., Bedi G., Haney M., Evans S.M., Rubin E., Foltin R.W., p. 162-167.
• Characteristics of drug users who witness many overdoses: implications for overdose prevention. Bohnert A.S., Tracy M., Galea S., p. 168-173.
• Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence. Nahvi S., Litwin A.H., Heo M., Berg K.M., Li X., Arnsten J.H., p. 174-180.
• Reward expectations lead to smoking uptake among depressed adolescents. Audrain-McGovern J., Rodriguez D., Rodgers K., Cuevas J., Sass J., Riley T., p. 181-189.
• Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians. Johanson C.E., Arfken C.L., di Menza S., Schuster C.R., p. 190-195.
• Negative reinforcement smoking outcome expectancies are associated with affective response to acute nicotine administration and abstinence. Robinson J.D., Lam C.Y., Carter B.L., Wetter D.W., Cinciripini P.M., p. 196-201.
• The effect of two elementary school-based prevention interventions on being offered tobacco and the transition to smoking. Wang Y., Storr C.L., Green K.M., Zhu S., Stuart E.A., Lynne-Landsman S.D., et al., p. 202-208.
• No influence of one right-sided prefrontal HF-rTMS session on alcohol craving in recently detoxified alcohol-dependent patients: results of a naturalistic study. Herremans S.C., Baeken C., Vanderbruggen N., Vanderhasselt M.A., Zeeuws D., Santermans L., et al., p. 209-213.
• Major depression and treatment response in adolescents with ADHD and substance use disorder. Warden D., Riggs P.D., Min S.J., Mikulich-Gilbertson S.K., Tamm L., Trello-Rishel K., et al., p. 214-219.
• The aldehyde dehydrogenase 2 gene is associated with heroin dependence. Wang T.Y., Lee S.Y., Chen S.L., Chen S.H., Chu C.H., Huang S.Y., et al., p. 220-224.
• The potential impact of recruitment method on sample characteristics and treatment outcomes in a psychosocial trial for women with co-occurring substance use disorder and PTSD. Winhusen T., Winstanley E.L., Somoza E., Brigham G., p. 225-228.
• Subjective and psychomotor effects of carisoprodol in combination with oxycodone in healthy volunteers. Zacny J.P., Paice J.A., Coalson D.W., p. 229-232.
• Reinstatement of methamphetamine seeking in male and female rats treated with modafinil and allopregnanolone. Holtz N.A., Lozama A., Prisinzano T.E., Carroll M.E., p. 233-237.
• A survey study to characterize use of Spice products (synthetic cannabinoids). Vandrey R., Dunn K.E., Fry J.A., Girling E.R., p. 238-241.
• Assessing teen smoking patterns: the weekend phenomenon. Bailey S.R., Jeffery C.J., Hammer S.A., Bryson S.W., Killen D.T., Ammerman S., et al., p. 242-245.
• Patterns and levels of illicit drug use among men who have sex with men in Asia. Wei C., Guadamuz T.E., Lim S.H., Huang Y., Koe S., p. 246-249.
• The Obsessive Compulsive Cocaine Use Scale: development and initial validation of a self-rated instrument for the quantification of thoughts about cocaine use. Hormes J.M., Coffey S.F., Drobes D.J., Saladin M.E., p. 250-254.
• Smoking-related prospective memory deficits in a real-world task. Heffernan T.M., O'Neill T.S., Moss M., p. 1-6.
• Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women. Janes A.C., Smoller J.W., David S.P., Frederick B.D., Haddad S., Basu A., et al., p. 7-13.
• Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment+naltrexone compared to usual care. Otiashvili D., Kirtadze I., O'Grady K.E., Jones H.E., p. 14-21.
• Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Cerda M., Wall M., Keyes K.M., Galea S., Hasin D., p. 22-27.
• Socializing in an open drug scene: the relationship between access to private space and drug-related street disorder. Debeck K., Wood E., Qi J., Fu E., McArthur D., Montaner J., et al., p. 28-34.
• Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Callaghan R.C., Cunningham J.K., Sykes J., Kish S.J., p. 35-40.
• MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity. Salomon R.M., Karageorgiou J., Dietrich M.S., McLellan J.Y., Charboneau E.J., Blackford J.U., et al., p. 41-47.
• Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial. DeFulio A., Everly J.J., Leoutsakos J.M., Umbricht A., Fingerhood M., Bigelow G.E., et al., p. 48-54.
• Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders. Svikis D.S., Keyser-Marcus L., Stitzer M., Rieckmann T., Safford L., Loeb P., et al., p. 55-64.
• Trazodone for sleep disturbance during methadone maintenance: a double-blind, placebo-controlled trial. Stein M.D., Kurth M.E., Sharkey K.M., Anderson B.J., Corso R.P., Millman R.P., p. 65-73.
• Craving and illicit heroin use among patients in heroin-assisted treatment. Blanken P., Hendriks V.M., Koeter M.W., van Ree J.M., van den Brink W., p. 74-80.
• Factors affecting cognitive function of opiate-dependent patients. Loeber S., Nakovics H., Kniest A., Kiefer F., Mann K., Croissant B., p. 81-87.
• Linking measures of adult nicotine dependence to a common latent continuum and a comparison with adolescent patterns. Strong D.R., Schonbrun Y.C., Schaffran C., Griesler P.C., Kandel D., p. 88-98.
• Exploring age of onset as a causal link between major depression and nonmedical use of prescription medications. Schepis T.S., McCabe S.E., p. 99-104.
• Changes in the plasma proteome follows chronic opiate administration in simian immunodeficiency virus infected rhesus macaques. Wiederin J.L., Yu F., Donahoe R.M., Fox H.S., Ciborowski P., Gendelman H.E., p. 105-112.
• Alcohol consumption among HIV-positive pregnant women in KwaZulu-Natal, South Africa: prevalence and correlates. Desmond K., Milburn N., Richter L., Tomlinson M., Greco E., van Heerden A., et al., p. 113-118.
• Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia. Couture M.C., Evans J.L., Sothy N.S., Stein E.S., Sichan K., Maher L., et al., p. 119-126.
• Beyond income: material resources among drug users in economically-disadvantaged New York City neighborhoods. Ompad D.C., Nandi V., Cerda M., Crawford N., Galea S., Vlahov D., p. 127-134.
• Modafinil for the treatment of methamphetamine dependence. Anderson A.L., Li S.H., Biswas K., McSherry F., Holmes T., Iturriaga E., et al., p. 135-141.
• Male injection drug users try new drugs following U.S. deportation to Tijuana, Mexico. Robertson A.M., Rangel M.G., Lozada R., Vera A., Ojeda V.D., p. 142-148.
• Counselor training in several evidence-based psychosocial addiction treatments in private US substance abuse treatment centers. Olmstead T.A., Abraham A.J., Martino S., Roman P.M., p. 149-154.
• Stressful life events and suicidal behavior in adults with alcohol use disorders: role of event severity, timing, and type. Conner K.R., Houston R.J., Swogger M.T., Conwell Y., You S., He H., et al., p. 155-161.
• Substance use after participation in laboratory studies involving smoked cocaine self-administration. Kalapatapu R.K., Bedi G., Haney M., Evans S.M., Rubin E., Foltin R.W., p. 162-167.
• Characteristics of drug users who witness many overdoses: implications for overdose prevention. Bohnert A.S., Tracy M., Galea S., p. 168-173.
• Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence. Nahvi S., Litwin A.H., Heo M., Berg K.M., Li X., Arnsten J.H., p. 174-180.
• Reward expectations lead to smoking uptake among depressed adolescents. Audrain-McGovern J., Rodriguez D., Rodgers K., Cuevas J., Sass J., Riley T., p. 181-189.
• Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians. Johanson C.E., Arfken C.L., di Menza S., Schuster C.R., p. 190-195.
• Negative reinforcement smoking outcome expectancies are associated with affective response to acute nicotine administration and abstinence. Robinson J.D., Lam C.Y., Carter B.L., Wetter D.W., Cinciripini P.M., p. 196-201.
• The effect of two elementary school-based prevention interventions on being offered tobacco and the transition to smoking. Wang Y., Storr C.L., Green K.M., Zhu S., Stuart E.A., Lynne-Landsman S.D., et al., p. 202-208.
• No influence of one right-sided prefrontal HF-rTMS session on alcohol craving in recently detoxified alcohol-dependent patients: results of a naturalistic study. Herremans S.C., Baeken C., Vanderbruggen N., Vanderhasselt M.A., Zeeuws D., Santermans L., et al., p. 209-213.
• Major depression and treatment response in adolescents with ADHD and substance use disorder. Warden D., Riggs P.D., Min S.J., Mikulich-Gilbertson S.K., Tamm L., Trello-Rishel K., et al., p. 214-219.
• The aldehyde dehydrogenase 2 gene is associated with heroin dependence. Wang T.Y., Lee S.Y., Chen S.L., Chen S.H., Chu C.H., Huang S.Y., et al., p. 220-224.
• The potential impact of recruitment method on sample characteristics and treatment outcomes in a psychosocial trial for women with co-occurring substance use disorder and PTSD. Winhusen T., Winstanley E.L., Somoza E., Brigham G., p. 225-228.
• Subjective and psychomotor effects of carisoprodol in combination with oxycodone in healthy volunteers. Zacny J.P., Paice J.A., Coalson D.W., p. 229-232.
• Reinstatement of methamphetamine seeking in male and female rats treated with modafinil and allopregnanolone. Holtz N.A., Lozama A., Prisinzano T.E., Carroll M.E., p. 233-237.
• A survey study to characterize use of Spice products (synthetic cannabinoids). Vandrey R., Dunn K.E., Fry J.A., Girling E.R., p. 238-241.
• Assessing teen smoking patterns: the weekend phenomenon. Bailey S.R., Jeffery C.J., Hammer S.A., Bryson S.W., Killen D.T., Ammerman S., et al., p. 242-245.
• Patterns and levels of illicit drug use among men who have sex with men in Asia. Wei C., Guadamuz T.E., Lim S.H., Huang Y., Koe S., p. 246-249.
• The Obsessive Compulsive Cocaine Use Scale: development and initial validation of a self-rated instrument for the quantification of thoughts about cocaine use. Hormes J.M., Coffey S.F., Drobes D.J., Saladin M.E., p. 250-254.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
M. CERDA ;
M. WALL ;
K. M. KEYES ;
S. GALEA ;
D. HASIN
|
2012
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : Périodique
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : Périodique
BACKGROUND: Marijuana is the most frequently used illicit substance in the United States. Little is known of the role that macro-level factors, including community norms and laws related to substance use, play in determining marijuana use, abuse[...]
K. DEBECK ;
E. WOOD ;
J. QI ;
E. FU ;
D. McARTHUR ;
J. MONTANER ;
T. KERR
|
2012
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : Périodique
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : Périodique
BACKGROUND: Limited attention has been given to the potential role that the structure of housing available to people who are entrenched in street-based drug scenes may play in influencing the amount of time injection drug users (IDU) spend on pu[...]
P. BLANKEN ;
V. M. HENDRIKS ;
M. W. J. KOETER ;
J. M. VAN REE ;
W. VAN DEN BRINK
|
2012
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : Périodique
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : Périodique
AIMS: To investigate in heroin-assisted treatment (HAT) compared to methadone maintenance treatment (MMT): the course of heroin craving and illicit heroin use, their mutual association, and their association with multi-domain treatment response.[...]
A. S. B. BOHNERT ;
M. TRACY ;
S. GALEA
|
2012
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : Périodique
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : Périodique
BACKGROUND: Programs to improve response of drug users when witnessing an overdose can reduce overdose mortality. Characteristics of drug users may be associated with the number of overdoses ever witnessed. This information could inform overdose[...]
C. E. JOHANSON ;
C. L. ARFKEN ;
S. DI MENZA ;
C. R. SCHUSTER
|
2012
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : Périodique
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : Périodique
BACKGROUND: Since 2003, buprenorphine has been approved for the treatment of opioid dependence in office-based practice. Diversion and abuse can be a threat to its continued approval under these conditions.
METHODS: As part of a national postm[...]
R. VANDREY ;
K. E. DUNN ;
J. A. FRY ;
E. R. GIRLING
|
2012
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : Périodique
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : Périodique
BACKGROUND: Synthetic cannabinoids are a rapidly emerging class of abused drugs. Synthetic cannabinoids are typically sold as "herbal blends" or "incense," commonly referred to as Spice products. No controlled human experiments have been conduct[...]